Pnc Financial Services Group, Inc. Cerus Corp Transaction History

Pnc Financial Services Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.97 - $7.93 $41,175 - $54,693	-6,897 Reduced 98.57%	100 $0
Q3 2021 Nov 05, 2021	BUY	$4.79 - $6.68 $33,036 - $46,071	6,897 Added 6897.0%	6,997 $42,000
Q3 2020 Nov 06, 2020	SELL	$5.78 - $7.47 $3,236 - $4,183	-560 Reduced 84.85%	100 $0
Q2 2020 Aug 07, 2020	BUY	$4.5 - $7.02 $450 - $702	100 Added 17.86%	660 $4,000
Q1 2020 May 08, 2020	SELL	$2.87 - $5.49 $7,499 - $14,345	-2,613 Reduced 82.35%	560 $2,000
Q4 2019 Feb 07, 2020	SELL	$3.84 - $4.86 $1.3 Million - $1.65 Million	-339,809 Reduced 99.07%	3,173 $13,000
Q3 2019 Nov 08, 2019	SELL	$4.86 - $6.05 $521,414 - $649,086	-107,287 Reduced 23.83%	342,982 $1.77 Million
Q2 2019 Aug 09, 2019	SELL	$4.51 - $6.6 $546,548 - $799,827	-121,186 Reduced 21.21%	450,269 $0
Q1 2019 May 10, 2019	SELL	$5.16 - $6.85 $154,335 - $204,883	-29,910 Reduced 4.97%	571,455 $0
Q4 2018 Feb 08, 2019	SELL	$4.89 - $7.16 $324,324 - $474,879	-66,324 Reduced 9.93%	601,365 $3.05 Million
Q3 2018 Nov 09, 2018	BUY	$6.89 - $7.78 $4.6 Million - $5.19 Million	667,689 New	667,689 $0

157

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $351M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.